Full Text
HTA58 Cost-Utility Analysis of Palivizumab to Prevent Respiratory Syncytial Virus Infections in the Dominican Republic

Abstract

Authors

Ordoñez J E. Porras

Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×